TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Bioflora AS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
979
|
972
|
914 |
| Financial expenses |
2
|
9
|
1 |
| Earnings before taxes |
85
|
77
|
34 |
| Total assets |
486
|
498
|
446 |
| Current assets |
486
|
498
|
446 |
| Current liabilities |
111
|
172
|
162 |
| Equity capital |
373
|
322
|
277 |
| - share capital |
8
|
9
|
9 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
76.7%
|
64.7%
|
62.1% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
8.7%
|
7.9%
|
3.7% |
| Return on assets (ROA) |
17.9%
|
17.3%
|
7.8% |
| Current ratio |
437.8%
|
289.5%
|
275.3% |
| Return on equity (ROE) |
22.8%
|
23.9%
|
12.3% |
| Change turnover |
57
|
116
|
-78 |
| Change turnover % |
6%
|
14%
|
-8% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.